National Health and health commission! It is required to do a good job in the preparation and use of varieties in the centralized drug purchase

According to the official website of the national health and Health Commission on December 19, recently, nine departments including the state health insurance bureau issued the implementation opinions on the pilot area expansion of centralized drug purchase and use organized by the state (health insurance Fa [2019] No 56), expanding the pilot area of centralized drug purchase and use organized by the state from "4 + 7" cities to the whole country The general office of the National Health Commission issued a notice on the relevant requirements in order to implement the work requirements, do a good job in the allocation and use of selected drugs, and let the reform results benefit more people The full text is as follows: Health and health committees of all provinces, autonomous regions, municipalities directly under the central government and Xinjiang production and Construction Corps: Recently, nine departments, including the state health insurance bureau, issued the implementation opinions on expanding the regional scope of national organization drug centralized purchase and use pilot (medical insurance Fa [2019] No 56), expanding the regional scope of national organization drug centralized purchase and use pilot from "4 + 7" cities to the whole country In order to implement the work requirements, do a good job in the allocation and use of selected drugs, and let the reform results benefit more people, the relevant requirements are hereby notified as follows: Health administrative departments and medical institutions at all levels should have a deep understanding of the great significance of the centralized purchase and use of drugs organized by the state in promoting the linkage of medical treatment, medical insurance and pharmaceutical reform, and in providing high-quality and cheap drugs, and attach great importance to the allocation and rational use of selected drugs in medical institutions The provincial health administrative departments shall take the centralized purchase and pilot expansion of drugs organized by the state as the key tasks for deployment, scientifically formulate implementation plans, put forward specific work requirements, strengthen organizational leadership and overall coordination, and ensure the smooth implementation of the expansion Each provincial health and health administrative department shall, in accordance with the agreed purchase volume reported by the region, urge and guide medical institutions (including public medical institutions and social medical institutions voluntarily participating in the pilot to expand the scope of the region) to allocate and use the selected drugs in a timely manner, so as to ensure the completion of the contract consumption on schedule The administrative department of health and medical institutions shall not influence the reasonable use and supply guarantee of the selected drugs on the grounds of cost control, drug proportion, requirements for drug varieties, specifications and quantities of medical institutions, examination and approval of Pharmaceutical Affairs Committee, etc Medical institutions should be guided by clinical needs, further optimize the drug use structure, and include the selected drugs in their drug formulary and basic drug supply catalogue The medical consortia is encouraged to implement a unified list of the supply of selected drugs, and implement the unified purchase and distribution of selected drugs Medical institutions should strengthen the management of rational use of selected drugs, standardize clinical drug use behavior by formulating and improving drug use guidelines, including selected drugs into clinical pathways, and strengthening the training of medical personnel Doctors should make reasonable prescriptions according to the diagnosis and treatment specifications, drug instructions, medication guidelines, etc., and give priority to the use of selected drugs on the premise of ensuring medical quality and safety The medical institutions shall strengthen the examination and evaluation of prescriptions, and the medical personnel who do not use the selected drugs in accordance with the regulations shall be seriously dealt with in accordance with the corresponding provisions of the prescription management measures and the hospital prescription evaluation management standard (Trial) We will encourage the provision of pharmaceutical services, such as pharmaceutical outpatient service, pharmaceutical restructuring, and pharmaceutical care, for key patients who use selected drugs Where conditions permit, the convenience of pharmaceutical services can be improved through information technology The main person in charge of the medical institution is the first person responsible for the allocation and use of the selected drugs All provincial health administrative departments and public medical institutions shall include the use of selected drugs in the performance appraisal and performance distribution of public medical institutions and their medical personnel For the medical institutions, clinical departments and doctors who give priority to rational use and ensure the amount of use, they should be inclined in the reform of public hospitals, such as bonus and supplementary funds, evaluation of excellence and evaluation of professional titles; for the public hospitals which can not be equipped as required or have insufficient purchase amount, or have serious clinical unreasonable use problems, they should be given in the evaluation of medical institutions and the evaluation of the objective responsibility of the person in charge of medical institutions Measures such as assessment and evaluation of unqualified drugs and notification within a certain range shall be taken to promote the formation of the guidance of encouraging the use of selected drugs On the basis of the performance evaluation of the third level public hospitals, the index of "proportion of selected drugs in the centralized purchase of drugs organized by the state" is gradually extended to the second level public hospitals We should fully mobilize the enthusiasm of the medical staff, balance the medical service revenue and expenditure, and use them as a whole for the payment of the medical staff according to the requirements of "two permits" Health administrative departments and medical institutions should use information technology to establish and improve the monitoring, evaluation and early warning system for the use of selected drugs Relying on the information platform of drug purchase and use, establish a smooth, timely and efficient information reporting and feedback channel, timely count the use information of selected drugs, monitor, analyze and evaluate the safety, effectiveness, rationality and economy of clinical use of selected drugs, and regularly report the monitoring results and relevant information For the situation that the use of selected drugs may lead to the adjustment of patients' drug use, the medical institutions should do a good job in clinical risk assessment, plan formulation, drug use monitoring and emergency response, and explain to patients The possible drug shortage or quality problems shall be warned in advance and reported to the health administration department in time The administrative departments of health and health at all levels should improve their political positions, carry out extensive publicity and training for medical personnel, so that they can deeply understand the significance of centralized and large-scale procurement of drugs organized by the state, give priority to the use of selected drugs in the diagnosis and treatment process, reasonably guide patients' medication habits, and do a good job in explanation and communication Local governments should strengthen policy interpretation and positive publicity, strive for the understanding and support of the public, especially the key sick people, improve patients' awareness of consistency evaluation and confidence in generic drugs, and create a good atmosphere of public opinion If you have any problems in the process of work, please contact our committee in time Our commission will timely organize research and inspection to ensure the smooth progress of the pilot project to expand the regional scope Tel: Medical Administration Bureau 010-68791976, 68792730 Fax: 010-68792206 General Office of the national health and Health Commission December 13, 2019 (form of information disclosure: active disclosure) Appendix: interpretation as follows Recently, the general office of the national health and Health Commission issued the notice of the general office of the national health and Health Commission on further improving the allocation and use of selected drugs in the centralized procurement of drugs organized by the state Now, the key points are explained as follows: Recently, nine departments, including the state health insurance bureau, issued the implementation opinions on expanding the regional scope of pilot drug centralized procurement and use organized by the state, expanding the regional scope of pilot drug centralized procurement and use organized by the state from "4 + 7" cities to the whole country In order to do a good job in the allocation and use of selected drugs, and let the reform results benefit more people, our committee drafted the notice on further completing the allocation and use of selected drugs in the centralized purchase of drugs organized by the state, and put forward specific requirements for relevant work （1） Attach great importance to the allocation and rational use of selected drugs It is required that the administrative departments of health and medical institutions at all levels should have a deep understanding of the significance of the centralized purchase and use of drugs organized by the state, strengthen the implementation of relevant work and systems, and ensure the smooth and smooth implementation of the expansion （2） We will ensure that policy channels for the use of selected drugs are unblocked All provincial health administrative departments are required to strengthen supervision and guidance The medical institutions shall unblock the policy channel of giving priority to the use of the selected drugs to ensure the completion of the agreed dosage （3） We will improve the rational use of selected drugs Medical institutions are required to strengthen the management of rational use of selected drugs and standardize clinical drug use behavior It is encouraged to provide pharmaceutical services such as pharmaceutical outpatient service and pharmaceutical care for the key patients who use the selected drugs.